Identifying and Managing NASH in High-Risk Populations

Learn from an expert about emerging strategies for combination treatment for NASH with GLP-1 receptor agonists plus SGLT2 inhibitors, from Clinical Care Options (CCO)

Manal F. Abdelmalek, MD, MPH Released: February 2, 2023

Experts review therapeutic interventions for NAFLD/NASH, from Clinical Care Options (CCO)

Manal F. Abdelmalek, MD, MPH
Program Director Rohit Loomba, MD, MHSc Brent Tetri, MD Physicians: maximum of 1.5 AMA PRA Category 1 Credits™ Registered Nurses: 1.5 Nursing contact hours Physician Assistants: 1.5 AAPA Category 1 CME Credits Released: December 7, 2022 Expired: December 6, 2023

Expert commentary on disease nomenclature based on underlying genetic factors, NASH heterogeneity, from Clinical Care Options (CCO)

Brent Tetri, MD Released: September 29, 2022

Expert insight on the burden and impact of HBV infection, as well as strategies to overcome barriers to vaccination, from Clinical Care Options (CCO)

Robert G. Gish, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: March 22, 2022 Expired: March 21, 2023